RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

CUSIP: 75955J402

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock ($.001 par value)
Shares outstanding
74,702,121
Total 13F shares
10,506,228
Share change
+1,150,045
Total reported value
$469,323,200
Put/Call ratio
4.7%
Price per share
$44.75
Number of holders
74
Value change
+$57,833,259
Number of buys
59
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2020

As of 30 Jun 2020, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,506,228 shares. The largest 10 holders included RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, VR Adviser, LLC, TANG CAPITAL MANAGEMENT LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Invesco Ltd., and BOXER CAPITAL, LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.